Tenzing Global Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-62,500
Closed -$5.13M 21
2024
Q2
$5.13M Buy
62,500
+20,000
+47% +$2.16M 3.29% 8
2024
Q1
$6.16M Buy
+42,500
New +$3.59M 5.6% 7

Other funds holding CDLX

Tenzing Global Management's CDLX Position: Q3 2024 in Review

Tenzing Global Management sold out of Cardlytics (CDLX) in Q3 2024, closing a stake of 62,500 shares — an estimated $5.13M sold.

Tenzing Global Management first reported a position in CDLX in Q1 2024 and held it in 2 quarters. The position peaked at $6.16M in Q1 2024. 111 funds tracked by Wall St. Rank hold CDLX as of Q3 2024.

  • Tenzing Global Management reported no remaining Cardlytics position as of Q3 2024 after selling out during the quarter.
  • Tenzing Global Management sold 62,500 Cardlytics shares in Q3 2024, an estimated $5.13M.
  • Tenzing Global Management first reported a position in Cardlytics in Q1 2024 and held it in 2 quarters.
  • Tenzing Global Management's Cardlytics position peaked at $6.16M in Q1 2024.
  • 111 funds tracked by Wall St. Rank held Cardlytics as of Q3 2024.

Based on Tenzing Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.